A detailed history of Free Gulliver LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Free Gulliver LLC holds 2,030 shares of ABT stock, worth $231,886. This represents 0.14% of its overall portfolio holdings.

Number of Shares
2,030
Previous 2,915 30.36%
Holding current value
$231,886
Previous $303 Million 23.59%
% of portfolio
0.14%
Previous 0.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$100.07 - $118.13 $88,561 - $104,545
-885 Reduced 30.36%
2,030 $231 Million
Q2 2024

Aug 13, 2024

BUY
$100.73 - $112.44 $41,802 - $46,662
415 Added 16.6%
2,915 $303 Million
Q1 2024

Aug 13, 2024

BUY
$109.52 - $120.96 $273,800 - $302,400
2,500 New
2,500 $284 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $200B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Free Gulliver LLC Portfolio

Follow Free Gulliver LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Free Gulliver LLC, based on Form 13F filings with the SEC.

News

Stay updated on Free Gulliver LLC with notifications on news.